Seòmar agus comataidhean

Registration opened on 15 June 2017, and delivery of Baby Boxes nationwide began on 15 August 2017 for all babies born and resident in Scotland.

We are unable to give the number of Baby Boxes delivered in the Dundee local authority area as we only record numbers of Baby Boxes distributed by Health Board area. We can provide the number of boxes delivered in Tayside Health Board.

The total number issued in NHS Tayside up to 3 February 2023 is 17,735 Baby Boxes.

The total breakdown is provided below:

The Scottish Government informed all relevant applicants on 19 December 2022 that the intention is to communicate next steps in relation to the Children, Young People, Families and Adult Learning third sector fund by the end of March 2023.

The Scottish Government’s Chief Scientist Office has not funded any research that is directly related to postural tachycardia from the years 2007 to today.

The Scottish Government’s Chief Scientist Office operates open competitive funding schemes for applied health research projects and fellowships across the wide range of NHS and health challenges in Scotland. These schemes are open to consideration of applications addressing research directed into postural tachycardia syndrome. Applications to these schemes are assessed through independent expert peer-review with funding recommendations made by independent expert committees.

I refer the member to the answer to question S6W-14934 on 8 March 2023. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at: https://www.parliament.scot/chamber-and-committees/questions-and-answers .

The financial assumptions contained with the Final Business and Regulatory Impact Assessment (BRIA) published in December 2021 show the projected cost to businesses in terms of compliance with the Scottish Deposit Return Scheme (DRS). The UK Government is responsible for providing details to industry regarding the potential financial impact of its DRS. We will continue to work closely with the UK and devolved governments to maximise interoperability of the schemes when they go live.

To date, we have been laying the foundations to deliver on Scotland’s first National Transitions to Adulthood Strategy to support disabled young people as they make the transition to young adult life, through research and engagement.

The scope, vision, aims and national priorities for the strategy will now be developed through external stakeholder engagement and wider consultation. Staffing costs for this work will be met from our operating costs budget for 2023-24.

The costs associated with the implementation of the Strategy will be determined by the actions that are developed and ultimately included, once agreed.

The global pandemic was the biggest shock our NHS has faced in its 74 year existence. Our NHS Recovery Plan published on 25 August 2021 invests £1 billion of targeted funding over five years to increase NHS capacity, deliver reform, and ensure everyone has the treatment they need at the right time, in the right place, and as quickly as possible.

The Scottish Government has sought advice from the Scottish Fire and Rescue Service regarding their views on making changes to muirburn legislation.

Forestry and Land Scotland sells the venison (deer carcasses in skin) produced on Scotland’s national forests and land to Approved Game Meat Handling Establishments (AGHE), not a ‘wholesaler’.

The volume sold to AGHEs broken down by financial year as follows:

The Scottish Government is committed to ensuring that people living in Scotland with long term conditions such as rheumatoid arthritis are able to access the best possible care and support.

The Scottish Government is working to ensure an overarching approach for advanced therapy medicinal products (ATMPs) is in place in order to facilitate a ‘once for Scotland’ approach, where possible. We recognise that there are wide-ranging implications and challenges for the managed introduction of these personalised medicines, and are committed to adopting a co-ordinated approach where practical. We are working across Government to develop our understanding of the future direction for this area of medicines policy, including associated genomic testing and service planning implications for the NHS.